Mirabegron in the management of lower urinary tract symptoms (LUTS) related to double-J (JJ) ureteral stents.
Phase of Trial: Phase III
Latest Information Update: 01 Sep 2017
At a glance
- Drugs Mirabegron (Primary)
- Indications Lower urinary tract symptoms
- Focus Therapeutic Use
- Acronyms BET-JJ
- 01 Sep 2017 Status changed from recruiting to discontinued.
- 05 Oct 2016 New trial record